{{Rsnum
|rsid=651007
|Chromosome=9
|position=133278431
|Orientation=minus
|GMAF=0.1896
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 2.7 | 35.4 | 61.9
| HCB | 3.7 | 26.5 | 69.9
| JPT | 1.8 | 43.4 | 54.9
| YRI | 1.4 | 24.5 | 74.1
| ASW | 3.5 | 19.3 | 77.2
| CHB | 3.7 | 26.5 | 69.9
| CHD | 2.8 | 27.5 | 69.7
| GIH | 2.0 | 24.8 | 73.3
| LWK | 3.6 | 22.7 | 73.6
| MEX | 3.4 | 17.2 | 79.3
| MKK | 1.9 | 18.1 | 80.0
| TSI | 10.8 | 28.4 | 60.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=20147318
|Title=Genetic variants in ABO blood group region, plasma soluble E-selectin levels, and risk of type 2 diabetes
|OA=1
}}

{{PMID Auto GWAS
|PMID=21909109
|Trait=None
|Title=Large-scale genome-wide association studies in East Asians identify new genetic loci influencing metabolic traits.
|RiskAllele=A
|Pval=6E-9
|OR=2.2778
|ORtxt=[1.51-3.05] mg/dL increase
}}

{{PMID Auto GWAS
  |PMID=23381943
  |Trait=End-stage coagulation
  |Title=Ischemic stroke is associated with the ABO locus: the EuroCLOT study.
  |RiskAllele=C
  |Pval=2E-25
  |OR=.46
  |ORtxt=[0.37-0.55] unit decrease
  |OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}